Which health technologies should be funded? A prioritization framework based explicitly on value for money.

Isr J Health Policy Res · 2012 · PMC3541977 · PMID 23181391

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Quality of evidence Especially for new technologies, there are likely to be significant differences between technologies with respect to the quality of their clinical evidence.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.